Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;55(2):169-71.
doi: 10.1016/j.molimm.2012.10.020. Epub 2012 Nov 30.

Alternative generation of MHC class II-restricted epitopes: not so exceptional?

Affiliations
Review

Alternative generation of MHC class II-restricted epitopes: not so exceptional?

Laurence C Eisenlohr. Mol Immunol. 2013 Sep.

Abstract

By convention, peptides presented at the cell surface by MHC class II molecules (MHCII) are derived from internalized ("exogenous") antigen that is denatured and fragmented in the endocytic compartment and loaded onto MHC in the late endosome with the assistance of the H2-DM chaperone. Over the past two decades several alternatives to this pathway have been described but the extent to which they contribute to natural CD4(+) T cell (T(CD4+))) responses has not been assessed, mainly because studies have focused primarily on individual epitopes. My laboratory has begun to address this issue in virus infection models and a picture is emerging in which classical presentation plays a relatively minor role, with a number of alternative presentation pathways collectively accounting for the majority of peptide presentation. The potential ramifications for this fundamentally altered view of MHCII peptide supply are discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Silverstein AM. A history of immunology. San Diego: Academic Press; 1989.
    1. Germain RN. Nature. 1986;322:687–689. - PubMed
    1. Jacobson S, Sekaly RP, Bellini WJ, Johnson CL, McFarland HF, Long EO. Annals of the New York Academy of Sciences. 1988;540:352–353. - PubMed
    1. Eisenlohr LC, Hackett CJ. Journal of Experimental Medicine. 1989;169:921–931. - PMC - PubMed
    1. Munz C. Annu Rev Immunol. 2009;27:423–449. - PubMed

MeSH terms

Substances